 | • レポートコード：MRC23Q37684 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、86ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のKRAS検査市場について調査・分析し、世界のKRAS検査市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（KRASサンガーシーケンス検査、KRAS核酸増幅検査（NAAT）、KRAS、その他）、用途別セグメント分析（大腸がん（CRC）、肺がん）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Qiagen NV、F. Hoffmann-La Roche Ltd,、Thermo Fisher Scientific Inc、Takara Bio Inc、Panagene Inc、Amoy Diagnostics Co Ltdなどが含まれています。世界のKRAS検査市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、KRAS検査市場規模を推定する際に考慮しました。本レポートは、KRAS検査の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、KRAS検査に関するビジネス上の意思決定に役立てることを目的としています。 ・KRAS検査市場の概要 - 製品の定義 - KRAS検査のタイプ別セグメント - 世界のKRAS検査市場規模：タイプ別分析（KRASサンガーシーケンス検査、KRAS核酸増幅検査（NAAT）、KRAS、その他） - KRAS検査の用途別セグメント - 世界のKRAS検査市場規模：用途別分析（大腸がん（CRC）、肺がん） - 世界のKRAS検査市場規模予測（2018年-2029年） - KRAS検査の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - KRAS検査市場の競争状況およびトレンド ・KRAS検査の地域別市場規模 - 北米のKRAS検査市場規模（2018年-2029年） - アメリカのKRAS検査市場規模（2018年-2029年） - ヨーロッパのKRAS検査市場規模（2018年-2029年） - アジア太平洋のKRAS検査市場規模（2018年-2029年） - 中国のKRAS検査市場規模（2018年-2029年） - 日本のKRAS検査市場規模（2018年-2029年） - 韓国のKRAS検査市場規模（2018年-2029年） - インドのKRAS検査市場規模（2018年-2029年） - オーストラリアのKRAS検査市場規模（2018年-2029年） - 中南米のKRAS検査市場規模（2018年-2029年） - 中東・アフリカのKRAS検査市場規模（2018年-2029年） ・タイプ別セグメント：KRASサンガーシーケンス検査、KRAS核酸増幅検査（NAAT）、KRAS、その他 - 世界のKRAS検査のタイプ別販売量（2018年-2023年） - 世界のKRAS検査のタイプ別売上（2018年-2023年） - 世界のKRAS検査のタイプ別価格 ・用途別セグメント：大腸がん（CRC）、肺がん - 世界のKRAS検査の用途別販売量（2018年-2023年） - 世界のKRAS検査の用途別売上（2018年-2023年） - 世界のKRAS検査の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Qiagen NV、F. Hoffmann-La Roche Ltd,、Thermo Fisher Scientific Inc、Takara Bio Inc、Panagene Inc、Amoy Diagnostics Co Ltd ・産業チェーンと販売チャネルの分析 - KRAS検査産業チェーン分析 - KRAS検査の主要原材料 - KRAS検査の販売チャネル - KRAS検査のディストリビューター - KRAS検査の主要顧客 ・KRAS検査市場ダイナミクス - KRAS検査の業界動向 - KRAS検査市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Kirsten Rat Sarcoma(KRAS)is a downstream signalling molecule in the EGFR cellular pathway with roles in cell growth and proliferation
Highlights
The global KRAS Tests market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for KRAS Tests is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for KRAS Tests is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of KRAS Tests include Qiagen NV, F. Hoffmann-La Roche Ltd,, Thermo Fisher Scientific Inc, Takara Bio Inc, Panagene Inc and Amoy Diagnostics Co Ltd, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for KRAS Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding KRAS Tests.
The KRAS Tests market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global KRAS Tests market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the KRAS Tests manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Qiagen NV
F. Hoffmann-La Roche Ltd,
Thermo Fisher Scientific Inc
Takara Bio Inc
Panagene Inc
Amoy Diagnostics Co Ltd
Segment by Type
KRAS Sanger sequencing Tests
KRAS Nucleic Acid Amplification Tests (NAAT)
KRAS Other Tests
Segment by Application
Colorectal Cancer (CRC)
Lung Cancer
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of KRAS Tests manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of KRAS Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 KRAS Tests Market Overview
1.1 Product Overview and Scope of KRAS Tests
1.2 KRAS Tests Segment by Type
1.2.1 Global KRAS Tests Market Value Comparison by Type (2023-2029)
1.2.2 KRAS Sanger sequencing Tests
1.2.3 KRAS Nucleic Acid Amplification Tests (NAAT)
1.2.4 KRAS Other Tests
1.3 KRAS Tests Segment by Application
1.3.1 Global KRAS Tests Market Value by Application: (2023-2029)
1.3.2 Colorectal Cancer (CRC)
1.3.3 Lung Cancer
1.4 Global KRAS Tests Market Size Estimates and Forecasts
1.4.1 Global KRAS Tests Revenue 2018-2029
1.4.2 Global KRAS Tests Sales 2018-2029
1.4.3 Global KRAS Tests Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 KRAS Tests Market Competition by Manufacturers
2.1 Global KRAS Tests Sales Market Share by Manufacturers (2018-2023)
2.2 Global KRAS Tests Revenue Market Share by Manufacturers (2018-2023)
2.3 Global KRAS Tests Average Price by Manufacturers (2018-2023)
2.4 Global KRAS Tests Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of KRAS Tests, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of KRAS Tests, Product Type & Application
2.7 KRAS Tests Market Competitive Situation and Trends
2.7.1 KRAS Tests Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest KRAS Tests Players Market Share by Revenue
2.7.3 Global KRAS Tests Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 KRAS Tests Retrospective Market Scenario by Region
3.1 Global KRAS Tests Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global KRAS Tests Global KRAS Tests Sales by Region: 2018-2029
3.2.1 Global KRAS Tests Sales by Region: 2018-2023
3.2.2 Global KRAS Tests Sales by Region: 2024-2029
3.3 Global KRAS Tests Global KRAS Tests Revenue by Region: 2018-2029
3.3.1 Global KRAS Tests Revenue by Region: 2018-2023
3.3.2 Global KRAS Tests Revenue by Region: 2024-2029
3.4 North America KRAS Tests Market Facts & Figures by Country
3.4.1 North America KRAS Tests Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America KRAS Tests Sales by Country (2018-2029)
3.4.3 North America KRAS Tests Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe KRAS Tests Market Facts & Figures by Country
3.5.1 Europe KRAS Tests Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe KRAS Tests Sales by Country (2018-2029)
3.5.3 Europe KRAS Tests Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific KRAS Tests Market Facts & Figures by Country
3.6.1 Asia Pacific KRAS Tests Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific KRAS Tests Sales by Country (2018-2029)
3.6.3 Asia Pacific KRAS Tests Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America KRAS Tests Market Facts & Figures by Country
3.7.1 Latin America KRAS Tests Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America KRAS Tests Sales by Country (2018-2029)
3.7.3 Latin America KRAS Tests Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa KRAS Tests Market Facts & Figures by Country
3.8.1 Middle East and Africa KRAS Tests Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa KRAS Tests Sales by Country (2018-2029)
3.8.3 Middle East and Africa KRAS Tests Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global KRAS Tests Sales by Type (2018-2029)
4.1.1 Global KRAS Tests Sales by Type (2018-2023)
4.1.2 Global KRAS Tests Sales by Type (2024-2029)
4.1.3 Global KRAS Tests Sales Market Share by Type (2018-2029)
4.2 Global KRAS Tests Revenue by Type (2018-2029)
4.2.1 Global KRAS Tests Revenue by Type (2018-2023)
4.2.2 Global KRAS Tests Revenue by Type (2024-2029)
4.2.3 Global KRAS Tests Revenue Market Share by Type (2018-2029)
4.3 Global KRAS Tests Price by Type (2018-2029)
5 Segment by Application
5.1 Global KRAS Tests Sales by Application (2018-2029)
5.1.1 Global KRAS Tests Sales by Application (2018-2023)
5.1.2 Global KRAS Tests Sales by Application (2024-2029)
5.1.3 Global KRAS Tests Sales Market Share by Application (2018-2029)
5.2 Global KRAS Tests Revenue by Application (2018-2029)
5.2.1 Global KRAS Tests Revenue by Application (2018-2023)
5.2.2 Global KRAS Tests Revenue by Application (2024-2029)
5.2.3 Global KRAS Tests Revenue Market Share by Application (2018-2029)
5.3 Global KRAS Tests Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Qiagen NV
6.1.1 Qiagen NV Corporation Information
6.1.2 Qiagen NV Description and Business Overview
6.1.3 Qiagen NV KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Qiagen NV KRAS Tests Product Portfolio
6.1.5 Qiagen NV Recent Developments/Updates
6.2 F. Hoffmann-La Roche Ltd,
6.2.1 F. Hoffmann-La Roche Ltd, Corporation Information
6.2.2 F. Hoffmann-La Roche Ltd, Description and Business Overview
6.2.3 F. Hoffmann-La Roche Ltd, KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
6.2.4 F. Hoffmann-La Roche Ltd, KRAS Tests Product Portfolio
6.2.5 F. Hoffmann-La Roche Ltd, Recent Developments/Updates
6.3 Thermo Fisher Scientific Inc
6.3.1 Thermo Fisher Scientific Inc Corporation Information
6.3.2 Thermo Fisher Scientific Inc Description and Business Overview
6.3.3 Thermo Fisher Scientific Inc KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Thermo Fisher Scientific Inc KRAS Tests Product Portfolio
6.3.5 Thermo Fisher Scientific Inc Recent Developments/Updates
6.4 Takara Bio Inc
6.4.1 Takara Bio Inc Corporation Information
6.4.2 Takara Bio Inc Description and Business Overview
6.4.3 Takara Bio Inc KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Takara Bio Inc KRAS Tests Product Portfolio
6.4.5 Takara Bio Inc Recent Developments/Updates
6.5 Panagene Inc
6.5.1 Panagene Inc Corporation Information
6.5.2 Panagene Inc Description and Business Overview
6.5.3 Panagene Inc KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Panagene Inc KRAS Tests Product Portfolio
6.5.5 Panagene Inc Recent Developments/Updates
6.6 Amoy Diagnostics Co Ltd
6.6.1 Amoy Diagnostics Co Ltd Corporation Information
6.6.2 Amoy Diagnostics Co Ltd Description and Business Overview
6.6.3 Amoy Diagnostics Co Ltd KRAS Tests Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Amoy Diagnostics Co Ltd KRAS Tests Product Portfolio
6.6.5 Amoy Diagnostics Co Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 KRAS Tests Industry Chain Analysis
7.2 KRAS Tests Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 KRAS Tests Production Mode & Process
7.4 KRAS Tests Sales and Marketing
7.4.1 KRAS Tests Sales Channels
7.4.2 KRAS Tests Distributors
7.5 KRAS Tests Customers
8 KRAS Tests Market Dynamics
8.1 KRAS Tests Industry Trends
8.2 KRAS Tests Market Drivers
8.3 KRAS Tests Market Challenges
8.4 KRAS Tests Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer